PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 46.36
-0.89 (-1.88%)
Jan 21, 2026, 4:00 PM EST
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 6.37 billion as of January 23, 2026. Its market cap has increased by 61.94% in one year.
Market Cap
6.37B
Enterprise Value
6.24B
Revenue
667.47M
Ranking
n/a
PE Ratio
181.01
Stock Price
46.36
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 6.37B, an increase of 61.70%. That is a compound annual growth rate of 16.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 6.37B | 55.01% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Konruns Pharmaceutical | 6.94B |
| Kexing Biopharm | 6.72B |
| R&G PharmaStudies | 6.72B |
| Xiangxue Pharmaceutical | 6.67B |
| Shanghai OPM Biosciences | 6.43B |
| Novogene | 6.11B |
| Hangzhou Biotest Biotech | 5.98B |
| Shenzhen Weiguang Biological Products | 5.96B |